Powder: -20°C for 3 years | In solvent: -80°C for 1 year
FHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 148.00 | |
5 mg | In stock | $ 372.00 | |
10 mg | In stock | $ 578.00 | |
25 mg | In stock | $ 933.00 | |
50 mg | In stock | $ 1,270.00 | |
100 mg | In stock | $ 1,690.00 | |
500 mg | In stock | $ 3,430.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 397.00 |
Description | FHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia. |
Molecular Weight | 562.66 |
Formula | C24H30N6O6S2 |
CAS No. | 2671128-05-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 245 mg/mL (435.43 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
FHD-286 2671128-05-3 Chromatin/Epigenetic Epigenetic Reader Domain Inhibitor inhibit FHD 286 FHD286 inhibitor